Antibody Market Size, Share, Growth & Industry Trends [2030]

Report Description

Antibody Market Outlook

The global antibody market size was valued at USD 147,431.4 Million in 2019 and is projected to reach USD 318,482.1 Million by 2027, expanding at a CAGR of 10.1% during the forecast period, 2020-2027. An antibody is a protein component of the body's immune system that recognizes and neutralizes foreign organisms such as bacteria and viruses. After being exposed to a foreign substance known as an antigen, antibodies stay in the blood and protect against further exposure to the antigen.

The demand for antibodies is growing owing to the increasing demand of fast recovery, growing number of patients with diabetic and cardiovascular disorders, rising number of research and development activities, and quick diagnosis techniques for dreadful diseases. Research and development activities in monoclonal antibodies are expected to create lucrative opportunities for the global antibody market in the future.

Get Free Sample Report

Antibody Market Dynamics

Testing kits are now available, allowing medical personnel and clinicians to acquire lab-quality, real-time diagnostic findings in minutes. Technological breakthroughs have improved the capabilities of testing systems. For example, the rapid antigen test for coronavirus is presented in minutes, allowing for quick and accurate sickness diagnosis.

Diseases are healed by administering the necessary antibodies in the form of a vaccination or drug. Researchers are concentrating on antigen detection technologies and developments. The number of people living with diabetes is rapidly increasing. Screening and early detection have the potential to save lives and avoid serious problems.

Self-monitoring of blood glucose (SMBG) allows people with diabetes to assess their own blood sugar levels using a glycemic reader and finger-prick technology. To achieve long-term glycemic management, SMBG technology employs lancets, test strips, and blood glucose metres.

Diabetes causes nerves and blood arteries that control the heart and blood flow in the body to deteriorate over time. As a result, an exogenous protein, such as insulin, is injected into the body to regulate blood sugar levels which is anticipated to fuel the growth of the market during the forecast period. 

The research and development sector is concerned with new efforts initiated by firms or governments in the development of new goods or services or the improvement of current ones. The primary focus is on biosimilar antibodies. In terms of worldwide expenditure, the research and development industry is at the top.

An increase in the number of R&D activities in the pharmaceutical and biotechnology industries biotechnology sectors, an increasing emphasis on the behaviour of various kinds of antibodies attaching to antigens, and product advancements are expected to fuel the market.

Healthcare is one of the most heavily regulated businesses on the planet. Clinical institutions and organizations must follow regulatory rules to preserve the privacy of patient information and the protection of healthcare workers in order to avoid fraud. Biotechnology and pharmaceutical industries demand large investments.

Antibodies, for example, are being studied in research. It takes time to develop monoclonal and polyclonal antibodies. Antibodies are coupled to antigens and injected into an organism for testing. The serum then collects the observation and transports it.

When the research is finished, the samples are sent to the FDA permission is required. The implementation of stringent rules is projected to impede the entry of new market competitors.

Antibody Market Segmental Insights

Type Segment Analysis

Based on types, the global antibody market is divided into monoclonal antibodies, polyclonal antibodies, ADCs, and others. Their use in the treatment of illnesses such as coronavirus, monoclonal antibodies are expected to have a large share of the market over the forecast period. Increase in cancer patients throughout the world, ADCs used to treat malignant tumours are rapidly growing popularity.

Monoclonal antibody drugs are expensive to manufacture, but they are widely available in the market, making them accessible to customers, which drives the market. Polyclonal antibodies are predicted to proliferate rapidly due to their ability to bind many antigen epitopes.

Get Free Sample Report

Technology Segment Analysis

In terms of technology, the global antibody market is classified into western blotting, flow cytometry, ELISA, immunohistochemistry, immunofluorescence, immunoprecipitation, and others. Owing to the precision, the western blotting segment is expected to occupy a considerable proportion of the market over the projection period.

Antibodies to HIV were detected as a consequence of the tests. Flow cytometry is thought to be rapidly expanding since it can do multi-parameter analysis on single cells inside a sample combination that is heterogeneous.

Application Segment Analysis

In terms of applications, the global antibody market is classified into proteomics, drug development, and genomics. Owing to the efficient mapping of drug-protein and protein-protein interactions, the proteomics sector is expected to occupy a major proportion of the market over the projected period.

The drug development segment is expected to expand rapidly, since it facilitates the release of sophisticated drugs and vaccines following FDA clearance. Attributing to advancements in genetic research of an organism and chances for cancer patients using stem cell treatment, the genomics segment is predicted to increase at a significant rate.

Get Free Sample Report

End-users Segment Analysis

Based on end-users, the global antibody market is classified as pharmaceutical and biotechnology companies, academic and research institutes, and CROs. The introduction of medicines and vaccines for horrible illnesses, pharmaceutical and biotechnology firms are expected to have a large proportion of the market throughout the predicted period.

CROs are expected to increase at a high rate, since they assist clinical studies of newly marketed vaccines and medications prior to market release. As a comprehensive study of illnesses is completed and a deep understanding of antigen is supplied, the academic and research institutions segment is predicted to increase at a quick rate.

Regional Outlook

Based on regions, the global antibody market is fragmented into North America, Europe, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2019. During the projected period, the market in Latin America, the Middle East and Africa, and Europe is expected to grow at a considerable CAGR.

During the forecast period, North America is expected to have the greatest share. Stem cell treatment research and technological improvements are offering attractive prospects for participants in this field.

Due to the increased frequency of chronic illnesses such as cardiovascular and blood illnesses, Europe is likely to occupy a significant market share. Due to research and development initiatives, Asia Pacific is a potential area for the antibody market. The collaboration of several medical institutes and academic institutions is expected to improve the situation.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Antibody Market
• Historical, Current and Projected Market Size in terms of Value
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on Global Antibody Market Performance